Back to top

Image: Bigstock

Interactive Brokers' December DARTs Show Y/Y Improvement

Read MoreHide Full Article

Interactive Brokers Group, Inc.’s (IBKR - Free Report) Electronic Brokerage segment reported a year-over-year increase in Daily Average Revenue Trades (DARTs) for December 2017. The segment deals in clearance and settlement of trades for individual and institutional clients globally.

Total client DARTs came in at 699,000, up 18% from December 2016 but down 12% from November 2017. Total customer accounts jumped 25% year over year and 2% from the prior month to 482,900 in the reported month.

Further, net new accounts totaled 8,900, surging a whopping 78% from the prior-year period but falling 6% from the last month. However, on an annualized basis, the company recorded Cleared Average DARTs per customer account of 342,000 in December. This reflects a decrease of 5% year over year and 13% from the previous month.

Interactive Brokers’ total option contracts came in at 24 million, increasing 10% from December 2016 but declining 14% from November 2017. Future contracts grew 11% from December 2016, however, fell 10% from the November 2017 level to 9.8 million.

At the end of December 2017, client equity was $124.8 billion, surging 46% year over year and 3% from the previous month. Also, Interactive Brokers recorded client credit balance of $47.1 billion in the reported month, up 13% year over year and relatively on par with the prior month. Furthermore, the company’s customer margin loan balance of $29.5 billion soared 52% from the prior-year period and 9% from the preceding month.

Interactive Brokers’ shares have gained 62.2% in 2017, outperforming the industry’s rally of 19.6%.



Currently, Interactive Brokers carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Among other investment brokers, TD Ameritrade Holding Corporation (AMTD - Free Report) , The Charles Schwab Corp. (SCHW - Free Report) and E*TRADE Financial Corp. are likely to come up with their respective monthly metrics information along with fourth-quarter 2017 earnings releases.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>